Cargando…

Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511]

Detalles Bibliográficos
Autores principales: Liu, Xinxue, Munro, Alasdair PS, Feng, Shuo, Janani, Leila, Aley, Parvinder K, Babbage, Gavin, Baxter, David, Bula, Marcin, Cathie, Katrina, Chatterjee, Krishna, Dejnirattisai, Wanwisa, Dodd, Kate, Enever, Yvanne, Qureshi, Ehsaan, Goodman, Anna L., Green, Christopher A, Harndahl, Linda, Haughney, John, Hicks, Alexander, van der Klaauw, Agatha A., Kwok, Jonathan, Libri, Vincenzo, Llewelyn, Martin J, McGregor, Alastair C, Minassian, Angela M., Moore, Patrick, Mughal, Mehmood, Mujadidi, Yama F, Holliday, Kyra, Osanlou, Orod, Osanlou, Rostam, Owens, Daniel R, Pacurar, Mihaela, Palfreeman, Adrian, Pan, Daniel, Rampling, Tommy, Regan, Karen, Saich, Stephen, Serafimova, Teona, Saralaya, Dinesh, Screaton, Gavin R, Sharma, Sunil, Sheridan, Ray, Sturdy, Ann, Supasa, Piyada, Thomson, Emma C, Todd, Shirley, Twelves, Chris, Read, Robert C., Charlton, Sue, Hallis, Bassam, Ramsay, Mary, Andrews, Nick, Lambe, Teresa, Nguyen-Van-Tam, Jonathan S, Cornelius, Victoria, Snape, Matthew D, Faust, Saul N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089831/
https://www.ncbi.nlm.nih.gov/pubmed/37055303
http://dx.doi.org/10.1016/j.jinf.2023.03.025
_version_ 1785022844178006016
author Liu, Xinxue
Munro, Alasdair PS
Feng, Shuo
Janani, Leila
Aley, Parvinder K
Babbage, Gavin
Baxter, David
Bula, Marcin
Cathie, Katrina
Chatterjee, Krishna
Dejnirattisai, Wanwisa
Dodd, Kate
Enever, Yvanne
Qureshi, Ehsaan
Goodman, Anna L.
Green, Christopher A
Harndahl, Linda
Haughney, John
Hicks, Alexander
van der Klaauw, Agatha A.
Kwok, Jonathan
Libri, Vincenzo
Llewelyn, Martin J
McGregor, Alastair C
Minassian, Angela M.
Moore, Patrick
Mughal, Mehmood
Mujadidi, Yama F
Holliday, Kyra
Osanlou, Orod
Osanlou, Rostam
Owens, Daniel R
Pacurar, Mihaela
Palfreeman, Adrian
Pan, Daniel
Rampling, Tommy
Regan, Karen
Saich, Stephen
Serafimova, Teona
Saralaya, Dinesh
Screaton, Gavin R
Sharma, Sunil
Sheridan, Ray
Sturdy, Ann
Supasa, Piyada
Thomson, Emma C
Todd, Shirley
Twelves, Chris
Read, Robert C.
Charlton, Sue
Hallis, Bassam
Ramsay, Mary
Andrews, Nick
Lambe, Teresa
Nguyen-Van-Tam, Jonathan S
Cornelius, Victoria
Snape, Matthew D
Faust, Saul N
author_facet Liu, Xinxue
Munro, Alasdair PS
Feng, Shuo
Janani, Leila
Aley, Parvinder K
Babbage, Gavin
Baxter, David
Bula, Marcin
Cathie, Katrina
Chatterjee, Krishna
Dejnirattisai, Wanwisa
Dodd, Kate
Enever, Yvanne
Qureshi, Ehsaan
Goodman, Anna L.
Green, Christopher A
Harndahl, Linda
Haughney, John
Hicks, Alexander
van der Klaauw, Agatha A.
Kwok, Jonathan
Libri, Vincenzo
Llewelyn, Martin J
McGregor, Alastair C
Minassian, Angela M.
Moore, Patrick
Mughal, Mehmood
Mujadidi, Yama F
Holliday, Kyra
Osanlou, Orod
Osanlou, Rostam
Owens, Daniel R
Pacurar, Mihaela
Palfreeman, Adrian
Pan, Daniel
Rampling, Tommy
Regan, Karen
Saich, Stephen
Serafimova, Teona
Saralaya, Dinesh
Screaton, Gavin R
Sharma, Sunil
Sheridan, Ray
Sturdy, Ann
Supasa, Piyada
Thomson, Emma C
Todd, Shirley
Twelves, Chris
Read, Robert C.
Charlton, Sue
Hallis, Bassam
Ramsay, Mary
Andrews, Nick
Lambe, Teresa
Nguyen-Van-Tam, Jonathan S
Cornelius, Victoria
Snape, Matthew D
Faust, Saul N
author_sort Liu, Xinxue
collection PubMed
description
format Online
Article
Text
id pubmed-10089831
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.
record_format MEDLINE/PubMed
spelling pubmed-100898312023-04-12 Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511] Liu, Xinxue Munro, Alasdair PS Feng, Shuo Janani, Leila Aley, Parvinder K Babbage, Gavin Baxter, David Bula, Marcin Cathie, Katrina Chatterjee, Krishna Dejnirattisai, Wanwisa Dodd, Kate Enever, Yvanne Qureshi, Ehsaan Goodman, Anna L. Green, Christopher A Harndahl, Linda Haughney, John Hicks, Alexander van der Klaauw, Agatha A. Kwok, Jonathan Libri, Vincenzo Llewelyn, Martin J McGregor, Alastair C Minassian, Angela M. Moore, Patrick Mughal, Mehmood Mujadidi, Yama F Holliday, Kyra Osanlou, Orod Osanlou, Rostam Owens, Daniel R Pacurar, Mihaela Palfreeman, Adrian Pan, Daniel Rampling, Tommy Regan, Karen Saich, Stephen Serafimova, Teona Saralaya, Dinesh Screaton, Gavin R Sharma, Sunil Sheridan, Ray Sturdy, Ann Supasa, Piyada Thomson, Emma C Todd, Shirley Twelves, Chris Read, Robert C. Charlton, Sue Hallis, Bassam Ramsay, Mary Andrews, Nick Lambe, Teresa Nguyen-Van-Tam, Jonathan S Cornelius, Victoria Snape, Matthew D Faust, Saul N J Infect Corrigendum The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association. 2023-05 2023-04-12 /pmc/articles/PMC10089831/ /pubmed/37055303 http://dx.doi.org/10.1016/j.jinf.2023.03.025 Text en © 2023 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Corrigendum
Liu, Xinxue
Munro, Alasdair PS
Feng, Shuo
Janani, Leila
Aley, Parvinder K
Babbage, Gavin
Baxter, David
Bula, Marcin
Cathie, Katrina
Chatterjee, Krishna
Dejnirattisai, Wanwisa
Dodd, Kate
Enever, Yvanne
Qureshi, Ehsaan
Goodman, Anna L.
Green, Christopher A
Harndahl, Linda
Haughney, John
Hicks, Alexander
van der Klaauw, Agatha A.
Kwok, Jonathan
Libri, Vincenzo
Llewelyn, Martin J
McGregor, Alastair C
Minassian, Angela M.
Moore, Patrick
Mughal, Mehmood
Mujadidi, Yama F
Holliday, Kyra
Osanlou, Orod
Osanlou, Rostam
Owens, Daniel R
Pacurar, Mihaela
Palfreeman, Adrian
Pan, Daniel
Rampling, Tommy
Regan, Karen
Saich, Stephen
Serafimova, Teona
Saralaya, Dinesh
Screaton, Gavin R
Sharma, Sunil
Sheridan, Ray
Sturdy, Ann
Supasa, Piyada
Thomson, Emma C
Todd, Shirley
Twelves, Chris
Read, Robert C.
Charlton, Sue
Hallis, Bassam
Ramsay, Mary
Andrews, Nick
Lambe, Teresa
Nguyen-Van-Tam, Jonathan S
Cornelius, Victoria
Snape, Matthew D
Faust, Saul N
Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511]
title Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511]
title_full Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511]
title_fullStr Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511]
title_full_unstemmed Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511]
title_short Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511]
title_sort corrigendum to “persistence of immunogenicity after seven covid-19 vaccines given as third dose boosters following two doses of chadox1 ncov-19 or bnt162b2 in the uk: three month analyses of the cov-boost trial” [j infect 84(6) (2022) 795–813, 5511]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089831/
https://www.ncbi.nlm.nih.gov/pubmed/37055303
http://dx.doi.org/10.1016/j.jinf.2023.03.025
work_keys_str_mv AT liuxinxue corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT munroalasdairps corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT fengshuo corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT jananileila corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT aleyparvinderk corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT babbagegavin corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT baxterdavid corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT bulamarcin corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT cathiekatrina corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT chatterjeekrishna corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT dejnirattisaiwanwisa corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT doddkate corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT eneveryvanne corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT qureshiehsaan corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT goodmanannal corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT greenchristophera corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT harndahllinda corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT haughneyjohn corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT hicksalexander corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT vanderklaauwagathaa corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT kwokjonathan corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT librivincenzo corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT llewelynmartinj corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT mcgregoralastairc corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT minassianangelam corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT moorepatrick corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT mughalmehmood corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT mujadidiyamaf corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT hollidaykyra corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT osanlouorod corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT osanlourostam corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT owensdanielr corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT pacurarmihaela corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT palfreemanadrian corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT pandaniel corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT ramplingtommy corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT regankaren corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT saichstephen corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT serafimovateona corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT saralayadinesh corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT screatongavinr corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT sharmasunil corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT sheridanray corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT sturdyann corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT supasapiyada corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT thomsonemmac corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT toddshirley corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT twelveschris corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT readrobertc corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT charltonsue corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT hallisbassam corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT ramsaymary corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT andrewsnick corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT lambeteresa corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT nguyenvantamjonathans corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT corneliusvictoria corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT snapematthewd corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT faustsauln corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511
AT corrigendumtopersistenceofimmunogenicityaftersevencovid19vaccinesgivenasthirddoseboostersfollowingtwodosesofchadox1ncov19orbnt162b2intheukthreemonthanalysesofthecovboosttrialjinfect84620227958135511